Bookbuilding IPO | ₹[.] Cr | Listing at NSE SME |
Multiplier AI Ltd. has filed its Draft Red Herring Prospectus (DRHP) with the exchange on to raise funds through Initial Public Offer (IPO) and is currently under process. This indicates that the DRHP is under review by the exchange.
Multiplier AI Ltd. IPO is a Book Build Issue
The equity shares are proposed to be listed on the NSE SME. Swastika Investmart Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue. Key details like IPO dates, IPO price bands and lot size are yet to be announced.
Refer to Multiplier AI IPO DRHP for more details.
| IPO Date | [.] |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | |
| Lot Size | |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Description | Date |
|---|---|
| Filed with SEBI/Exchange | Mon, Sep 30, 2024 |
| Offer document withdrawn | Wed, Feb 19, 2025 |
| Filed with SEBI/Exchange | Thu, Feb 27, 2025 |
Incorporated in July 2011, Multipliers AI Limited provides AI solutions to pharmaceutical companies through advanced analytics, predictive modeling, and marketing.
The company offers AI solutions, including Gen AI Doctor Data Platform, Hyper Personalized Content, DPDP Compliant HCP Marketing, GPT & LLM Tools for Pharmaceutical companies, and platforms for patient intelligence, doctor referrals, and attracting new patients, enabling clients to adapt to market changes and seize opportunities quickly.
The company utilizes advanced AI algorithms to generate personalized content, analyze patient data, and identify key physician influencers.
The company's clientele spans global pharmaceutical giants, healthcare providers, and specialized firms.
The company offers the following services:
As of February 2025, the company has 59 clients in total.
As of December 31, 2024, the company had 84 dedicated professionals, with no contracted employees on its payroll.
Competitive Strength
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 17.16 | 13.47 | 11.85 | 7.95 |
| Total Income | 7.02 | 11.65 | 15.75 | 10.30 |
| Profit After Tax | 3.24 | 4.10 | 1.33 | 0.63 |
| NET Worth | 13.02 | 9.79 | 5.68 | 4.35 |
| Reserves and Surplus | 4.60 | 9.38 | 5.28 | 3.95 |
| Amount in ₹ Crore | ||||
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 41.90% |
| RoNW | 41.90% |
| PAT Margin | 36.58% |
| Pre IPO | Post IPO | |
|---|---|---|
| Promoter Holding | 100% |
Lead Manager Reports
Multiplier AI IPO is a SME IPO of 0 equity shares of the face value of ₹10 aggregating up to ₹[.] Crores. The issue is priced at To be declared. The minimum order quantity is .
The Multiplier AI IPO open and close dates are not available as of now.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in Multiplier AI IPO using UPI as a payment gateway. Zerodha customers can apply in Multiplier AI IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Multiplier AI IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Multiplier AI IPO dates are not announced. Please check back again after some time.
Multiplier AI IPO lot size and the minimum order quantity is not available at this time. Please check again later.
You can apply in Multiplier AI IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Multiplier AI IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Multiplier AI IPO allotment status.
The Multiplier AI IPO listing date is not yet announced. The tentative date of listing is .
